CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise | +12,224 | 16,808 | ||
| 2024-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Shares withheld for taxes | −5,905 | $5.61 | $33K | 10,903 |
| 2024-03-07 | Kelly James Patrick EVP, CFO and Treasurer | Option exercise · Restricted Stock Units | −12,224 | 24,446 | ||
| 2024-03-01 | Trizzino John EVP, CCO and CBO | Grant or award · Restricted Stock Units | +144,000 | 144,000 | ||
| 2024-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Grant or award · Restricted Stock Units | +120,000 | 120,000 | ||
| 2024-03-01 | Kelly James Patrick EVP, CFO & Treasurer | Grant or award · Restricted Stock Units | +176,000 | 176,000 | ||
| 2024-03-01 | Dubovsky Filip President, R&D | Grant or award · Restricted Stock Units | +144,000 | 144,000 | ||
| 2024-03-01 | Casey Mark J EVP, CLO & Corporate Secretary | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2024-03-01 | Jacobs John C President and CEO | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2024-03-01 | Jacobs John C President and CEO | Grant or award · Restricted Stock Units | +250,000 | 250,000 | ||
| 2024-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise | +19,600 | $5.39 | $106K | 19,600 |
| 2024-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Shares withheld for taxes | −5,375 | $5.39 | $29K | 14,225 |
| 2024-03-01 | O'Hara Elaine EVP, Chief Strategy Officer | Option exercise · Restricted Stock Units | −19,600 | 39,200 | ||
| 2024-01-23 | Jacobs John C President and CEO | Option exercise | +83,197 | 83,197 | ||
| 2024-01-23 | Jacobs John C President and CEO | Shares withheld for taxes | −40,093 | $4.26 | $171K | 43,104 |
| 2024-01-23 | Jacobs John C President and CEO | Option exercise · Restricted Stock Units | −83,197 | 166,393 | ||
| 2023-12-14 | Trizzino John EVP, CCO and CBO | Option exercise | +1,600 | 11,428 | ||
| 2023-12-14 | Trizzino John EVP, CCO and CBO | Shares withheld for taxes | −773 | $5.69 | $4K | 10,655 |
| 2023-12-14 | Trizzino John EVP, CCO and CBO | Option exercise · Restricted Stock Units | −1,600 | 0 | ||
| 2023-12-14 | Herrmann John A III EVP, Chief Legal Officer | Option exercise | +2,100 | 13,933 |
Page 13 of 14 · 279 trades